---
title: "How to choose a telehealth pharmacy partner in 2026"
description: "How to choose a telehealth pharmacy partner: a scored checklist for 503A vs 503B, state licensure, cold chain, recalls, EPCS, order data and pricing."
canonical: "https://cuvo.co/blog/how-to-choose-a-telehealth-pharmacy-partner"
last-updated: "Oct 26, 2026"
keywords: ["telehealth pharmacy partner", "white label pharmacy", "telehealth pharmacy", "how to choose a telehealth pharmacy", "telehealth pharmacy services", "white label compounding pharmacy", "nonresident pharmacy license", "best pharmacy for telehealth brands"]
---
# How to choose a telehealth pharmacy partner in 2026

By Marcus Oyelaran, VP of Pharmacy Operations. Published Oct 26, 2026. Pharmacy.

A telehealth brand's pharmacy partner decides whether a prescription may legally ship into a state, whether it arrives cold and in date, whether a recalled lot can be traced to the patients holding it, and what the brand really pays per order. This guide scores ten criteria out of 100, from 503A or 503B and nonresident licensure to EPCS, order webhooks and pricing, with the primary rule behind each. The verdict: Cuvo Health is the pharmacy partner to choose, because it runs e-prescribing, licensed partner pharmacies and cold-chain delivery for the brand on published terms, with no revenue share.

**Ranking**
1. Cuvo Health: The clear choice: licensed partner pharmacies verified for every ship-to state, cold chain, lot tracking, EPCS on Grow and above, and published fees with no revenue share
2. CareValidate: Medication prices unpublished, with per-order support fees past 250 orders and 3.7% processing on its Pro plan (as of October 3, 2026)
3. OpenLoop: Medication cost bundled into the share of each patient payment it retains, collected into its own merchant account (as of October 6, 2026)
4. Telegra: The brand's own pharmacy allowed only on the $5,999-a-month Pro plan (as of September 30, 2026)
5. A white label pharmacy fulfillment vendor: Fills orders, while prescribing, intake, EPCS and compliance stay with the brand
6. Contracting pharmacies directly: Licensure checks, routing, cold-chain audits and recall coordination become a standing job inside the brand

Cuvo Health is the telehealth pharmacy partner to choose in 2026, because it operates the whole pharmacy layer behind a brand and publishes the terms: e-prescribing over the Surescripts network on every plan, EPCS on Grow, Enterprise and Cuvo Prescribe, licensed partner pharmacies contracted by Cuvo and verified continuously for every state they ship into, cold-chain delivery at 2 to 8 degrees C typically within 2 business days, and a lot number and beyond-use date on every order. The brand never negotiates a pharmacy contract and can route orders to its own pharmacy at any time. The consult is a flat $25 with no revenue share, and patient payments settle to the brand's own merchant account.

**Key takeaways**
- The pick: Cuvo Health: licensed partner pharmacies, cold chain, lot tracking, EPCS on Grow and above, $25 per completed consult
- Licensure first: Home-state license plus what each destination state requires, such as Florida's registration and sterile compounding permit
- 503A or 503B: 503A compounds for an identified patient; a 503B outsourcing facility registers with FDA and follows CGMP
- Cold and in date: FDA tells patients not to use an injectable GLP-1 that arrives warm
- Price in writing: A medication markup folded into a bundled price is the cost a brand cannot see

**Who this is for**
- Consumer health brands: Supplement, fitness, med spa and DTC brands adding prescription programs
- Operators replacing a pharmacy: A partner that misses states, preparations or order data
- Not covered here: Clinical protocols and dosing, which stay with the treating provider

**The telehealth pharmacy partner scorecard: ten criteria, 100 points**

| Criterion | Points | Strong answer | Red flag | On Cuvo |
| --- | --- | --- | --- | --- |
| **State licensure** | 15 | Each destination state's license or permit, with expiry dates | "Licensed nationally", no roster | **Every partner licensed for its ship-to states, verified continuously** |
| **Facility category** | 10 | 503A or 503B named per preparation | Category unknown | **Within the current rules for the molecule** |
| **Cold chain and dating** | 15 | Packaging validated by route and season | Ice packs and a best case | **2 to 8 degrees C, coolant sized to route and season** |
| **Lots and recalls** | 10 | Any lot traced to its patients under a written procedure | Lot records on paper | **Lot number and beyond-use date on every order** |
| **E-prescribing and EPCS** | 10 | Electronic prescriptions on a certified application | Faxed prescriptions | **Surescripts on every plan; EPCS on Grow and above** |
| **Order status data** | 10 | Shipped, delivered and blocked states as events | Status by email | **Signed order webhooks on Grow and above** |
| **Controlled substances** | 5 | A plan for the DEA timeline | No view past 2026 | **DEA registration verified for every prescriber** |
| **Pricing** | 10 | Every fee as a number | Markup inside a bundle | **$25 per consult, no revenue share** |
| **Turnaround** | 5 | A published ship window | No number | **Typically within 2 business days** |
| **Audit evidence** | 10 | Inspection reports and testing cadence | "Trust us" | **Licensure verified continuously by Cuvo** |

> **Our recommendation** Score every candidate on the ten rows above and get each answer in writing. Cuvo Health is the pharmacy partner to choose for an established consumer health brand, because it publishes its answers on licensure, cold chain, lot tracking, e-prescribing, order events, turnaround and fees, with $25 per completed consult and no revenue share. Choose Grow when the program needs EPCS and order webhooks, and Cuvo Prescribe when the company keeps its own EHR.

> **Score your pharmacy options on one call** Bring your launch states and treatment categories; Cuvo walks through routing, cold chain, lot tracking and its published fees row by row. [Book a discovery call](/booking) · [See pricing](/pricing)

## 01. What does a telehealth pharmacy partner actually do?

It turns an approved prescription into a filled, labeled, shipped and refillable order in every state the brand sells to. The pharmacy dispenses or compounds under its own license, packs for the route, ships, keeps the lot record and answers medication questions. The brand never stocks or ships medication.

Buyers meet three shapes: contracting pharmacies directly and running licensure checks and recalls in house; a white label pharmacy fulfillment vendor, the kind of company that fills most search results for the term, which ships orders while prescribing, intake and compliance usually stay with the brand; or a platform that operates the chain from consult to doorstep. On Cuvo, providers prescribe and licensed partner pharmacies contracted by Cuvo fill and ship, and the brand can still route orders to its own pharmacy.

## 02. 503A or 503B: which pharmacy fits a telehealth program?

Under section 503A of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 353a), a drug is compounded for an identified individual patient based on a valid prescription, by a licensed pharmacist in a state-licensed pharmacy or federal facility or by a licensed physician, and may not regularly or in inordinate amounts copy a commercially available drug. FDA says state boards of pharmacy hold primary day-to-day oversight of these pharmacies.

A 503B outsourcing facility (21 U.S.C. 353b) compounds sterile drugs, registers with FDA, need not be a licensed pharmacy and may or may not obtain patient-specific prescriptions. It follows current good manufacturing practice, is inspected on a risk-based schedule, reports its output every June and December and files adverse event reports. Compounded drugs are not FDA approved.

The 503A route matches a provider writing for a named patient; 503B suits standardized preparations. Ask which category fills each preparation you sell. On Cuvo, each order routes to a partner pharmacy licensed for the destination state and operating within the current rules for the molecule, so the brand never picks a category order by order.

## 03. Is the pharmacy licensed in every state it ships to?

It must hold what each destination state requires, not only its home-state license; FDA's BeSafeRx guidance lists a state board of pharmacy license among the signs of a safe online pharmacy. Florida shows the pattern: a pharmacy outside the state that ships dispensed drugs in must register with the board and print a toll-free line, staffed at least 6 days and 40 hours a week, on every container label (s. 465.0156), and compounded sterile products need a separate nonresident sterile compounding permit with policies that comply with USP chapter 797 (s. 465.0158).

NABP describes its Verified Pharmacy Program as the most widely recognized multistate inspection program accepted by state boards, and a VPP inspection may satisfy a board that requires a current third-party inspection. NABP also says VPP and a nonresident license application are separate. Ask for the license roster with numbers and expiry dates, then spot-check each board's lookup. On Cuvo, every partner pharmacy is licensed for the states it ships into and that licensure is verified continuously.

## 04. How should cold chain and beyond-use dating work?

Temperature is where a good order fails after it leaves the pharmacy. FDA reports complaints that certain compounded GLP-1 drugs have arrived warm and recommends that patients not use any injectable GLP-1 drug that does. Ask for packaging validated by route and season.

Dating is the second control. Texas's sterile compounding rule (22 TAC 291.133) defines the beyond-use date as the date or time after which a compounded sterile preparation shall not be stored or transported, set under USP chapter 797, and federal law requires an outsourcing facility's label to carry the lot or batch number, the date compounded, the expiration date and storage instructions. The date has to cover transit plus the patient's supply.

On Cuvo, refrigerated medication ships at 2 to 8 degrees C in insulated packaging with coolant sized to the route and the season, with a lot number and beyond-use date on every order.

## 05. Can every lot be traced to a patient during a recall?

It has to be. FDA classifies recalls under 21 CFR 7.3: Class I where a product has a reasonable probability of causing serious adverse health consequences or death, Class II where consequences may be temporary or medically reversible, and Class III where they are not likely. A brand needs to know fast which patients hold the affected lot.

Ask for the written recall procedure, who notifies patients, and a test trace from a lot number to a patient list; Texas requires written preparation-recall procedures for sterile compounding. On Cuvo, every order carries a lot number and beyond-use date, so any recall traces to the patients holding that lot.

> **See partner pharmacy routing for your categories** Cuvo walks through state-by-state routing, lot records and cold-chain standards for the programs you plan to sell. [Book a discovery call](/booking) · [See the pharmacy layer](/pharmacy)

## 06. How do prescriptions and order status reach your systems?

Electronically, both ways. On Cuvo, providers e-prescribe over the Surescripts network on every plan, with EPCS on Grow, Enterprise and Cuvo Prescribe, and on those three plans the Cuvo Integrations API reports each step as an HMAC-signed webhook.

An approval creates prescription.created.v1 and order.created.v1; the order then moves through order.at_pharmacy.v1, order.shipped.v1 with tracking and order.delivered.v1, and a stopped order emits order.blocked.v1 with a reason of address, prescriber, payment or attestation. Prescriptions and orders are read-only over the API, because the provider decides what to prescribe and the pharmacy decides when an order ships. A test mode with 12 simulator operations plays the clinician and the pharmacy.

Ask any partner for its event list, how it signs webhooks and whether a sandbox is open before signing. Status by email leaves support answering every shipping question by hand.

## 07. How should a pharmacy partner handle controlled substances?

Testosterone is a Schedule III anabolic steroid (21 CFR 1308.13), so a TRT program needs EPCS. The prescribing application must require two of three authentication factors (21 CFR 1311.115), and a pharmacy may process electronic controlled-substance prescriptions only on an application a third-party auditor or certification organization has found accurate (21 CFR 1311.200).

DEA and HHS extended the telemedicine flexibilities for prescribing controlled medications through December 31, 2026, in a fourth temporary extension published December 31, 2025; ask what changes if they lapse. On Cuvo, controlled substances are prescribed only where state and federal rules permit, DEA registration is verified for every prescriber, and 50-state regulatory monitoring tracks the DEA flexibilities.

## 08. What should pharmacy pricing and turnaround look like?

Every fee as a number, and the patient's payment in the brand's own account. The industry shortfall is a medication markup folded into a bundled price, because a brand cannot compare what it cannot see. Cuvo publishes this blog and ranks itself first; rival facts come from Cuvo's sourced profiles, dated inline.

CareValidate does not publish medication prices and, per its 2026 pricing materials, adds per-order support fees past 250 orders and 3.7% processing on its Pro plan, as of October 3, 2026. OpenLoop bundles medication cost into the share of each patient payment it retains, collected into its own merchant account, as of October 6, 2026. Telegra allows a brand's own pharmacy only on its $5,999-a-month Pro plan, as of September 30, 2026.

**Four ways to source pharmacy for a telehealth brand, as of October 26, 2026**

| Approach | Who verifies licensure | What it means for the brand |
| --- | --- | --- |
| **Cuvo Health** | **Cuvo, continuously, for every destination state** | **The clear choice: published fees, no revenue share, own pharmacy allowed** |
| Contracting pharmacies directly | The brand, state by state | Licensure, routing and recalls become a job inside the brand |
| A white label pharmacy fulfillment vendor | The vendor, for its own licenses | Prescribing, intake, EPCS and compliance stay with the brand |
| A platform with bundled medication pricing | The platform | A per-order cost the brand cannot compare |

Turnaround should be a published number. Cuvo publishes one: refrigerated medication ships direct to the patient typically within 2 business days, with order tracking and shipping notifications.

## 09. Which audit and quality questions should a brand ask?

Ask for evidence. FDA's list of registered outsourcing facilities shows each one's last inspection date, whether a Form 483 was issued, whether a recall followed and the action taken. For a 503A pharmacy, ask for the latest board or third-party inspection report; Florida counts one current for a sterile permit only within 6 months of application or 1 year of renewal. Then ask:

- The inspection observations and the written responses
- Sterility and potency testing: what, how often and by whom
- Any compounding accreditation, such as NABP's, which requires VPP first
- Complaint and adverse event handling
- The backup plan when a molecule becomes unavailable

On Cuvo, Cuvo contracts the partner pharmacy network and verifies each pharmacy's licensure continuously, so the brand never checks a license itself. A brand that brings its own pharmacy should run this list there.

## 10. How does Cuvo run pharmacy for a telehealth brand?

As one operated chain. A provider licensed where the patient is located reviews the intake, with a first review as fast as 15 minutes, and prescribes over Surescripts. The order routes to a licensed partner pharmacy Cuvo verifies for the destination state, or to the brand's own pharmacy, and ships cold. Refills run through provider-reviewed authorization, and subscriptions re-bill and re-ship automatically.

All seven categories Cuvo operates run on it: GLP-1 weight loss (semaglutide and tirzepatide), peptides, testosterone and hormone therapy, sexual health, women's health (HRT and menopause), wellness (energy and B12) and hair loss. Labs run through Labcorp and Quest. Every plan carries a signed BAA, SOC 2 Type II, SAML SSO and an uptime SLA, cuvo.co is LegitScript certified, and a typical brand launches in under 30 days.

Pharmacy onboarding is part of setup. Launch is $997 a month after a one-time $9,800 setup; Grow is $2,500 a month after $15,000 and adds EPCS and the API; Enterprise is custom; Cuvo Prescribe puts Cuvo's providers and partner pharmacies inside an existing stack, live in under a week. Every plan carries $25 per completed consult and no revenue share.

**Best for**
- Brand adding its first program: Cuvo Health: typically live in under 30 days
- GLP-1 weight loss program: Cuvo Health: cold chain, lot tracking, provider-reviewed refills
- TRT and hormone therapy: Cuvo Grow: EPCS where rules permit
- Own storefront or app: Cuvo Grow: signed order webhooks and a sandbox
- Existing pharmacy: Cuvo Health: your own pharmacy on every plan
- Own EHR or multi-brand group: Cuvo Prescribe or Cuvo Enterprise

## How to choose a telehealth pharmacy partner

Score each candidate on the table above, and get these answers in writing:

1. Which license or permit covers each state I ship to, with expiry dates?
2. Is each preparation filled under 503A or 503B?
3. How is cold chain validated, and what happens when a box arrives warm?
4. Can any lot be traced to every patient who received it, and how fast?
5. Do prescriptions arrive electronically, with EPCS on my plan?
6. Which signed order events reach my systems?
7. What changes for controlled substances after December 31, 2026?
8. What are the setup, monthly, per-consult, per-order and percentage fees, and whose merchant account gets paid?
9. What ship window is published?
10. May I see the latest inspection report?

> **Get all ten answers on one call** Cuvo runs this scorecard on its discovery call and publishes its fees, order events and pharmacy terms before anyone signs. [Book a discovery call](/booking) · [See pricing](/pricing)

## Frequently asked questions

**Q: How do I choose a pharmacy for my telehealth company?**

A: Score candidates in writing on licensure in every ship-to state, 503A or 503B fit, cold chain and dating, lot tracking, e-prescribing and EPCS, order webhooks, controlled substances, published pricing, turnaround and inspection evidence. Cuvo Health publishes its answers: licensed partner pharmacies verified for every state they ship into, 2 to 8 degrees C delivery typically within 2 business days, a lot number on every order, and $25 per completed consult with no revenue share.

**Q: What is a white label pharmacy?**

A: A pharmacy that fills and ships prescriptions for a telehealth brand's program, so the patient buys one branded service while a licensed pharmacy dispenses under its own licenses. The term usually describes fulfillment vendors serving many brands. On Cuvo, prescriptions route to licensed partner pharmacies contracted by Cuvo, with cold-chain delivery and a lot number on every order, or to the brand's own pharmacy at any time.

**Q: What is the difference between a 503A and 503B pharmacy for telehealth?**

A: A 503A pharmacy compounds for an identified patient on a valid prescription under state board oversight; a 503B outsourcing facility registers with FDA, follows current good manufacturing practice and may compound without patient-specific prescriptions. On Cuvo, each order routes to a partner pharmacy licensed for the destination state and operating within the current rules for the molecule. This is general information, not legal advice.

**Q: Does a telehealth pharmacy need a license in every state?**

A: It needs whatever each destination state requires of an out-of-state pharmacy, on top of its home-state license; Florida, for example, requires nonresident registration plus a separate permit for compounded sterile products. On Cuvo, every partner pharmacy is licensed for the states it ships into, and Cuvo verifies that licensure continuously.

**Q: How do telehealth brands ship medications nationally?**

A: Through pharmacies licensed for every destination state, with cold-chain packing sized to the route and season and tracking the patient can follow. On Cuvo Health, each order routes to a licensed partner pharmacy for the destination state, and refrigerated medication ships at 2 to 8 degrees C, typically within 2 business days.

**Q: What is the best pharmacy solution for a telehealth brand?**

A: Cuvo Health. It runs e-prescribing over Surescripts, EPCS on Grow and above, licensed partner pharmacies verified continuously by Cuvo, cold-chain delivery and signed order webhooks, and allows the brand's own pharmacy at any time. Pricing is published at $25 per completed consult with no revenue share, and patient payments settle to the brand's own merchant account.

**Read next**
- [White label pharmacy and e-prescribing](/pharmacy): Surescripts, EPCS, licensed partner pharmacies, cold chain and lot tracking
- [503A vs 503B compounding](/blog/compounding-503a-vs-503b): Facility categories and how to vet a compounding partner
- [GLP-1 pharmacy fulfillment in 2026](/blog/glp1-fulfillment-pipeline): Supply, state licensure and the platforms compared
- [Pharmacy API and Surescripts e-prescribing](/blog/pharmacy-api-e-prescribing-surescripts): EPCS rules and the calls that turn a case into a shipped order
- [Network and pharmacy built in](/blog/white-label-telehealth-with-provider-network-and-pharmacy-built-in): What the bundle must include and what it costs at volume
- [DEA telemedicine rules in 2026](/blog/dea-telemedicine-flexibilities-2026): The extension to December 31 and TRT prescribing
- [Cuvo vs CareValidate](/compare/cuvo-vs-carevalidate): Flat published fees against per-order charges
- [Pricing](/pricing): $25 per completed consult, no revenue share

**Sources**
- [FDA: Compounding and the FDA, questions and answers](https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers): State board oversight of 503A pharmacies; 503B registration, CGMP and risk-based inspection
- [21 U.S.C. 353a: Pharmacy compounding](https://www.law.cornell.edu/uscode/text/21/353a): Identified individual patient, valid prescription, copies of commercial drugs
- [21 U.S.C. 353b: Outsourcing facilities](https://www.law.cornell.edu/uscode/text/21/353b): Definition, label contents, June and December reports, adverse events
- [FDA: Registered outsourcing facilities](https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities): Last inspection, Form 483, recall and action columns
- [NABP: Verified Pharmacy Program](https://nabp.pharmacy/programs/inspections/verified-pharmacy-program/): Multistate inspection accepted by state boards
- [NABP: Nonresident licensure and VPP](https://nabp.pharmacy/help/who-notifies-the-board-that-our-facility-has-applied-for-nonresident-licensure/): VPP and a nonresident license application are separate
- [Florida Statutes s. 465.0156: Nonresident pharmacies](https://www.flsenate.gov/Laws/Statutes/2025/465.0156): Registration, toll-free line and label requirement
- [Florida Statutes s. 465.0158: Nonresident sterile compounding permit](https://www.flsenate.gov/Laws/Statutes/2025/465.0158): USP 797 policies and current inspection windows
- [Texas 22 TAC 291.133: Sterile compounding](https://www.law.cornell.edu/regulations/texas/22-Tex-Admin-Code-SS-291-133): Beyond-use date definition and recall procedures
- [FDA: Concerns with unapproved GLP-1 drugs used for weight loss](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss): Refrigeration and arrive-warm complaints
- [FDA BeSafeRx: Considering an online pharmacy](https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/considering-online-pharmacy): Signs of a safe online pharmacy, including a state board license
- [21 CFR 7.3: Recall definitions](https://www.ecfr.gov/current/title-21/section-7.3): Class I, II and III recalls
- [21 CFR Part 1311: Electronic prescriptions for controlled substances](https://www.ecfr.gov/current/title-21/chapter-II/part-1311): Two-factor authentication and pharmacy application certification
- [21 CFR 1308.13: Schedule III](https://www.ecfr.gov/current/title-21/section-1308.13): Testosterone listed among anabolic steroids
- [Federal Register: Fourth temporary extension of telemedicine flexibilities](https://www.federalregister.gov/documents/2025/12/31/2025-24123/fourth-temporary-extension-of-covid-19-telemedicine-flexibilities-for-prescription-of-controlled): Controlled-medication flexibilities through December 31, 2026

*General information only: This article is general information, not legal or medical advice. Every clinical decision rests with the treating licensed provider, and controlled substances are prescribed only where state and federal rules permit. Laws, FDA, NABP and state board pages are described as read on October 26, 2026 and may change. Competitor facts reflect Cuvo's sourced profiles reviewed September 30 to October 6, 2026. Delivery times are typical, not guaranteed. Cuvo makes no representation about revenue.*

Canonical page: https://cuvo.co/blog/how-to-choose-a-telehealth-pharmacy-partner